Latest News

• share
• favorite_border

The findings could shed light on sickle cell diseases and other disorders where red blood cells are deformed.

• share
• favorite_border

Scientists at The Scripps Research Institute have discovered a new aspect of the flu virus and how it interacts with antibodies in the lungs.

• share
• favorite_border

“This study is a good example of a host/pathogen arms race playing out in real-time—this time with the host a likely winner."

• share
• favorite_border

The Skaggs Graduate School of Chemical and Biological Sciences at The Scripps Research Institute is ranked among the top ten in the nation according to a recent survey by U.S. News & World Report.

• share
• favorite_border

TSRI scientists investigate a phenomenon that may guard against disease as we age.

• share
• favorite_border

Researchers at The Scripps Research Institute (TSRI) have designed a new molecule-building method that uses sulfones as partners for cross-coupling reactions, or the joining of two distinct chemical entities in a programmed fashion aided by a catalyst.

• share
• favorite_border

Scientists at The Scripps Research Institute (TSRI) have now shown a path to developing treatments for disease subtype CMT2D.

• share
• favorite_border

‘This study identifies the missing link between Lewy bodies and the type of damage that’s been observed in neurons affected by Parkinson’s."

• share
• favorite_border

Scientists on the Florida campus of The Scripps Research Institute (TSRI) have discovered a new target for treating major depressive disorder, a disease that affects more than 16 million American adults.

• share
• favorite_border

The breakthrough may expand research on the roles of glycans in human diseases, including cancers.

• share
• favorite_border

These new areas of interest belong to the so-called “non-coding” genome—the 98 percent of the genome that doesn’t directly code for proteins but instead regulates how key proteins are produced.

• share
• favorite_border

A team from The Scripps Research Institute (TSRI) has revealed that by crossing two species of flies, they can use what they learn from the proteome of the hybrid offspring to find new clues about how proteins interact with each other

• share
• favorite_border

“These results lay the groundwork for the next steps toward FDA approval,” says John Griffin, PhD, professor at TSRI, whose team invented 3K3A-APC.

• share
• favorite_border

Researchers at The Scripps Research Institute (TSRI) have developed a quick and easy way to simultaneously modify dozens of drugs or molecules to improve their disease-fighting properties.

• share
• favorite_border

The researchers will spend the next five years collecting data from Ebola and Lassa survivors to learn how they fought off the virus.

• share
• favorite_border

A study from scientists at The Scripps Research Institute (TSRI) explains why the risk of osteoarthritis increases as we age and offers a potential avenue for developing new therapies to maintain healthy joints.

• share
• favorite_border

Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug.

• share
• favorite_border

Understanding how the dynein-dynactin complex is assembled and organized provides a critical foundation to explain the underlying causes of several dynein-related neurodegenerative diseases.

• share
• favorite_border

TSRI scientists identify molecule that fuels cancer metastasis.

• share
• favorite_border

The five-year grant will support five individual research projects and three core resources at the TSRI Alcohol Research Center.